Alerts
View all our safety alerts, medicine shortage alerts and product recalls.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Complementary medicines (2)
- (-) Shortages (2)
- Alert/Advisory (12)
- Medicine safety (8)
- Prescription medicines (5)
- Safety (5)
- Australian Register of Therapeutic Goods (ARTG) (3)
- Listed medicines (3)
- Medical devices safety (3)
- Regulatory compliance (3)
- Import and export (2)
- Advertising (1)
- Labelling and packaging (1)
- Non-prescription medicines (1)
- Over the counter (OTC) medicines (1)
- Therapeutic goods regulation (1)
- Weight loss products (1)
Search
4 result(s) found, displaying 1 to 4
-
Market actionsBrauer Natural Medicine is recalling several batches of its Baby & Child Teething Gel, 20 g, due to the potential for a small plastic fragment from the tube rim being present in the gel.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Safety alertsWe are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.